This Month in Muscular Dystrophy   /     Dr. Jerry Mendell Discusses Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy :: March 2015

Description

Guest: Jerry Mendell, MD, is Director of the Center for Gene Therapy in The Research Institute, Director of the Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, and Curran-Peters Chair of Pediatric Research at Nationwide Children’s Hospital. He is also an attending neurologist at Nationwide Children’s and a professor of pediatrics and neurology at The Ohio State University College of Medicine.• View the published abstract for this month’s featured research article.• Learn more about the gene therapy trial for Becker Muscular Dystrophy.

Subtitle
Dr. Jerry Mendell Discusses Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy :: March 2015
Duration
14:39
Publishing date
2015-03-23 19:17
Link
http://feedproxy.google.com/~r/This-Month-in-Muscular-Dystrophy/~3/DiDXh3kEpiM/jerry-mendell-discusses-phase-12a-follistatin-gene-therapy-trial-for-becker-muscular-dystrophy
Contributors
  Kevin Flanigan, MD
author  
Enclosures
http://sas-origin.OnstreamMedia.com/origin/nationwidechildrens/Research/jerry-mendell-discusses-phase-1-2a-follistatin-gene-therapy-trial-for-becker.mp3
audio/mpeg